Clin2
NCT07342829Likely a fitNot yet recruiting

Booster vaccine follow-up study

Monkeypox (Mpox)

Part of Infections clinical trials.

This study follows people who are getting a booster dose of the MVA-BN vaccine, which is used to protect against mpox. The goal is to see how the booster works and monitor any side effects.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
95 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are scheduled to receive a booster dose of the MVA-BN vaccine.
  • You are 18 years of age or older.
  • You are willing to provide written consent to participate.
  • You are willing to follow the study schedule, including any follow-up visits.
  • You have not had a past or current mpox infection.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07253675Not yet recruiting· Phase 2
Testing a new smallpox and mpox vaccine in the Democratic Republic of the Congo

This study tests a new vaccine designed to protect against smallpox and mpox. It aims to see if the vaccine is safe and triggers a good immune response in people aged 2 to 45.

NCT06840860Recruiting
EPIC study: testing for VMPX

This study tests people for VMPX to learn more about the condition and to understand how it affects the body. You can join if you are willing to be tested and can give permission.

Kinshasa, Masina
NCT07067723Enrolling by invitation
Mpox outbreak study in the Democratic Republic of Congo

This study is for people in the Democratic Republic of Congo who have been diagnosed with mpox. Researchers want to learn more about how the virus spreads and how it affects people during this outbreak.

Mbandaka, Équateur Province
NCT05879965Recruiting
Tracking immune responses after mpox, smallpox vaccine, or PrEP

This study follows people after confirmed mpox, after smallpox vaccination, or in people taking HIV PrEP to learn how the immune system responds over time. It may help scientists better understand protection and immune changes after these exposures.

Antwerp
NCT06885853Recruiting
Long-term immune response to mpox booster in men on PrEP

This study tests how well a booster dose of the MVA-BN mpox vaccine keeps working over time in men who are on or starting PrEP for HIV prevention.

Paris, Paris
NCT05627713Recruiting
Studying monkeypox infection and vaccine in adults

This study looks at the medical and lab changes in people with suspected or likely monkeypox, and in adults who may be eligible for a monkeypox vaccine. Your participation helps researchers understand how infection and vaccination affect the body and how to improve care.

Paris

Hear when a new Monkeypox (Mpox) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.